Most Recent Publications:

Hughes AR, Bullimore MA, Elliott DB. Ease of adaptation predicts patients’ preference and happiness with new spectacles better than visual acuity. Clin Exp Optom 2024:1-8.

Joseph A, Bullimore M, Drawnel F, et al. Remote Monitoring of Visual Function in Patients with Maculopathy: The Aphelion Study. Ophthalmol Ther 2024;13:409-22.

Bullimore MA, Morgan IG, Ohno-Matsui K, Saw SM. As Far as the Eye Can See: Importance of Myopia as a Pressing Public Health Need. Ophthalmol Sci 2024;4:100438

Bullimore MA, Brennan NA. Juvenile-Onset Myopia—Who to Treat and How to Evaluate Success? Eye (Lond) 2024;38:450-4.

Logan N, Bullimore MA. Optical Interventions for Myopia Control. Eye (Lond) 2024;38:455-63.

Jawaid I, Saunders K, Hammond C, Dahlmann-Noor A, Bullimore MA, Brennan NA. Low Concentration Atropine and Myopia: A Narrative Review of the Evidence for United Kingdom Based Practitioners. Eye (Lond) 2024;38:434-41.

Bullimore MA, Brennan NA. The underestimated role of myopia in uncorrectable visual impairment in the United States. Sci Rep 2023;13:15283.

Bullimore MA, Liu. Efficacy of the Euclid orthokeratology lens in slowing axial elongation. Cont Lens Anterior Eye 2023.

Bullimore MA, Lee SS, Schmid KL, et al. IMI - Onset and progression of myopia in young adults. Invest Ophthalmol Vis Sci 2023;64:2.

Sankaridurg P, Berntsen DA, Bullimore MA, et al. IMI - 2023 Digest. Invest Ophthalmol Vis Sci 2023;64:7.

Richdale K, Skidmore KV, Tomiyama ES, Bullimore MA. Compounded 0.01% Atropine-What's in the Bottle? Eye Contact Lens 2023;49:219-23.

Lattery LJ, Chao C, Walline J, Bullimore MA, Ritchey ER, Skidmore K, Richdale K. Patient and Parent Perceptions of Myopia Modalities. Cont Lens Anterior Eye 2023;46:101772.  

Bullimore MA, Brennan NA, Flitcroft.The Future of Clinical Trials in Myopia Control. Ophthalmic Physiol Opt 2023;43:525-33.

Bullimore MA, Richdale K. Incidence of Corneal Adverse Events in Children Wearing Soft Contact Lenses. Eye Contact Lens 2023;49:204-11.

Bullimore MA, Brennan NA. Efficacy in Myopia Control—The Low-Concentration Atropine for Myopia Progression (LAMP) Study. Ophthalmology 2023;130:771-2.

Zhang J, Wu Y, Sharma B, et al. Epidemiology and Burden of Astigmatism: A Systematic Literature Review. Optom Vis Sci 2023;100:218-31.

Bullimore MA, Brennan NA. Efficacy in Myopia Control—Does Race Matter? Optom Vis Sci 2023;100:5-8.

Bullimore MA, Brennan NA. Myopia: An Ounce of Prevention is Worth a Pound of Cure. Ophthalmic Physiol Opt 2023;43:116-121.

Ducloux L, Marillet S, Ingrand P, Bullimore MA, Bourne R, Leveziel N. Progression of myopia in teenagers and adults: a nationwide longitudinal study of a prevalent cohort. Br J Ophthalmol 2023;107:644-9. 

Richdale K, Tomiyama ES, Novack GD, Bullimore MA. Compounding of Low-Concentration Atropine for Myopia Control. Eye Contact Lens 2022;48:489-92.

Flitcroft DI, Bullimore MA, Jong M. Broader Implications of Overminus Lens Therapy in Relation to Myopia Management. JAMA Ophthalmology 2022;140:97-8.

Schanzlin D, Owen JP, Klein S, Yeh TN, Merchea MM, Bullimore MA. Efficacy of Systane iLux Thermal Pulsation System for the Treatment of Meibomian Gland Dysfunction after 1 week and 1 month: a Prospective Study. Eye Contact Lens 2022;48:155-61.

Tricard D, Marillet S, Ingrand P, Bullimore MA, Bourne R, Leveziel N. Progression of myopia in children and teenagers: a nationwide longitudinal study. Br J Ophthalmol 2022;106:1104-9.

Gao Y, Lim EW, Yang A, Drobe B, Bullimore MA. The Impact of Spectacle Lenses for Myopia Control on Visual Functions. Ophthal Physiol Opt 2021;41:1320-1331.

Bullimore MA, Mirsayafov DS, Khurai AR, Kononov LB, Asatrian SP, Shmakov AN, Richdale K, Gorev VV. Pediatric Microbial Keratitis with Overnight Orthokeratology in Russia. Eye Contact Lens 2021;47:420-5.

Bullimore MA, Ritchey ER, Shah S, Leveziel N, Bourne RRA, Flitcroft DI. The risks and benefits of myopia control. Ophthalmology 2021;128:1561-1579

Chamberlain P, Lazon de la Jara P, Arumugam B, Bullimore MA. Axial Length Targets for Myopia Control. Ophthalmic Physiol Opt, 2021;41:523-531.

Richdale K, Cox I, Kollbaum P, Bullimore MA, Bakaraju RC, Gifford P, Plainis S, McKenney C, Newman S, Tomiyama ES. Contact Lens Evidence-based Academic Report (CLEAR): Contact Lens Optics. Cont Lens Anterior Eye 2021;44:220-239.

Brennan NA, Cheng X, Toubouti Y, Bullimore MA. Efficacy in Myopia Control. Prog Retin Eye Res 2021;83:100923.

Zhang J, Liu J, Jasti S, Suryakumar R, Bullimore MA. Visual Acuity Demand of Chinese vs English Newspapers. Optom Vis Sci 2020;97:865-870.

Bullimore MA, Flanagan JG. Letter from America. Ophthal Physiol Opt, 2020;40:708-709.

Bullimore MA, Brennan NA. Comment on: ‘Cochrane corner: Atropine: an ancient remedy for a twenty-first century problem?’ Eye 2021;35:2638–2639.

Bullimore MA, Richdale K. Myopia Control 2020: Where are we and where are we heading? Ophthal Physiol Opt 2020;40:254–270.

Bullimore MA, Johnson L. Overnight orthokeratology. Cont Lens Anterior Eye 2020;43;322–332.

Tauber J, Owen J, Bloomenstein M, Hovanesian J, Bullimore MA. Comparison of the iLux and the LipiFlow for the treatment of meibomian gland dysfunction and symptoms: a randomized clinical trial. Clin Ophthalmol 2020;14:405–418.

Bullimore MA, Brennan NA. Myopia control–why every diopter matters. Optom Vis Sci 2019;96:463-465.

Bullimore MA, Slade S, Yoo P, Otani T. An Evaluation of the IOLMaster 700. Eye Contact Lens  2019;45:117-123.